Abstract
Several new 1,1′-bis(sulfonyl)ferrocenes designed for the synthesis of sulfonamide linked biological conjugates have been prepared. 1,1′-Bis(sulfonylbromide)ferrocene can be produced from the corresponding sulfonylchloride via a bis(sulfonylhydrazide) intermediate. Bis(sulfonyl-N-hydroxybenzotriazole)ferrocene can also be synthesized from the sulfonyl chloride, and reaction of glycine methyl ester with the sulfonyl chloride affords a [3]ferrocenophane complex. All new compounds have been structurally characterized by X-ray crystallography.
Keywords: hydroxybenzotriazole, ferrocene, ferrocenophane, sulfonyl bromide, sulfonyl hydrazide
Graphical Abstract
New 1,1′-bis(sulfonyl)ferrocenes designed for the synthesis of sulfonamide linked biological conjugates have been prepared. 1,1′-Bis(sulfonylbromide)ferrocene can be produced from the corresponding sulfonylchloride via a bis(sulfonylhydrazide) intermediate. Bis(sulfonyl-N-OBt)ferrocene can be synthesized from the sulfonyl chloride, and reaction of glycine methyl ester with the sulfonyl chloride affords a [3]ferrocenophane complex.

Introduction
The linking of organometallic units with molecules of biological relevance, including biological macromolecules, has been receiving increasing attention over the past three decades.[1–5] One area of particular activity is amide bond formation between two amino acids or peptides to separate rings of ferrocene.[6–8] The most commonly studied systems is based on 1,1′-ferrocene dicarboxylic acid; 1′-aminoferrocene-1-carboxylic acid and ferrocene-1,1′-diamine have been studied as well.[9,10] By producing 1,1′-bis(substituted) ferrocene complexes, unusual hydrogen bonding interactions between the amino acid groups can be achieved. The method of amide bond formation to generate bis(substituted) species has led to a wealth of new compounds and information on their hydrogen bonded structures.
Recently, we have started to explore bis(sulfonamide) based conjugates to examine differences from the amide based complexes.[11] In this communication, we examine alternative methods to 1,1′-ferrocene bis(sulfonamides) derived from 1,1′-bis(sulfonylchloride)ferrocene, including the bis(sulfonylhydrazide), bis(sulfonylbromide) and bis(sufonylhydroxybenzatriazole) modified ferrocenes. Additionally, we observed that reaction with glycine methyl ester results in a new bio-organometallic ferrocenophane. All of these compounds, which are shown in Scheme 1, can be readily prepared from easily synthesized starting materials, and can be used as precursors for generating biologically relevant conjugate complexes.
Scheme 1.
Reactions referred to in this paper.
Results and Discussion
1,1′-Bis(sulfonylchloride) ferrocene 1 can be readily generated in three steps from ferrocene via reaction with chlorosulfonic acid, isolation as the ammonium salt, and then reaction with PCl5.[12] Previously, we have shown that 1 can be used to generate both mono- and bis(sulfonamide) derivatives.[11] The sulfonyl chloride is useful in that it exhibits selectivity in reactivity with amines under wet (i.e. non-dried) conditions, however reactions with amines frequently requires higher temperatures or extended reaction times. In order to make more rapidly reacting reagents, we decided to prepare the bis(sulfonylbromide) analog of 1. Sulfonyl bromides have been prepared for aryl compounds,[13,14] but not for ferrocenes. We used the same synthetic methodology for aryl sulfonyl bromides, preparing bis 1,1′-(sulfonylhydrazide)ferrocene 2 via reaction of 1 with hydrazine. We fully characterized compound 2, including via X-ray crystallography, as shown in Figure 1. The structure of 2 shows a nearly eclipsed conformation of cyclopentadienyl rings, with an angle of ~72° between the -SO2NHNH2 groups on the cyclopentadienyl groups. The bond lengths of the sulfonylhydrazide unit are as expected for this functional group,[15–17] with an S-N bond length averaging ~1.64 Å and an average N-N bond length of ~1.41 Å. In the solid state, we observe intermolecular hydrogen bonding between the SO2 units and the NHNH2 groups (S-N distances ranging between ~2.86 and ~3.03 Å) as well as between hydrazine functional groups in the solid (N-N distance of ~3.01 Å). 1,1′-Bis-(sulfonylbromide)ferrocene 3 can be produced from 2 via reaction with elemental bromine and purified via column chromatography. Compound 3 was also structurally characterized (Figure 1) and this complex is structurally similar to compound 1, but with the expected longer S-Br bond length of 2.2066(8) Å. Notably, this is the first reported crystal structure of a sulfonyl bromide compound. As in 1, the compound adopts an anti conformation with the two sulfonyl bromide groups at an angle of 180° and the bromides are each pointing away from the ferrocene. We observed that compound 3 reacts avidly with primary amines under room temperature conditions to produce the corresponding 1,1′-bis(sulfonamide) ferrocene compounds.
Figure 1.

The molecular structures of 2 (top left), 3 (top right) and 4 (bottom) with 50% thermal ellipsoids. Hydrogen atoms have been omitted for clarity.
An alternative method for the formation of amide bonds is to use hydroxybenzotriazole, HOBt, as the leaving group.[18–23] This unit has been successfully used for the activation of carbonyl functionalized ferrocenes for the formation of amino acid conjugates.[22,24] HOBt has been used occasionally to activate sulfonic acid derivatives[25,26] and we hypothesized that a similarly structured sulfonyl group would allow for the rapid generation of ferrocene bis(sulfonamides). Thus, we prepared compound 4, 1,1′-bis(sulfonyl-N-hydroxybenzotriazole)ferrocene, which is produced from the reaction of compound 1 with 1-hydroxybenzotriazole hydrate. The resultant product can be purified via silica gel chromatography, and we were able to fully characterize compound 4 including via X-ray crystallography (Figure 1). The ferrocene adopts a staggered anti conformation, with the -SO2OBt groups arranged at 180° to each other in the solid. The plane of the OBt unit is tilted by ~38° from the plane of the cyclopentadienyl group. As in the 1,1′-bis(sulfonylbromide)ferrocene described above, compound 4 also reacts avidly with amines to produce the corresponding bis-1,1′ (sulfonamide)ferrocene compounds
As we were investigating the amino acid chemistry of compound 1, we observed an unusual reaction with glycine methyl ester. For most primary amines, we observe either the formation of mono or bi-functionalized ferrocene sulfonamides.[11] However in the case of glycine methyl ester, we observed the formation of a [3]ferrocenophane, compound 5. Ferrocenophanes have been reported using a variety of bridging groups to link the two cyclopentadienyl rings.[27–32] We were able to fully characterize this compound, including via single crystal X-ray methods, as shown in Figure 2. As can be seen in the structure, the amine terminus of the glycine bridges the two cyclopentadienyl rings via -SO2N(R)SO2-linkages, resulting in a three atom connection. Due to the number of atoms involved in the bridge and the length of both the S-C and S-N bonds, there is little strain in this ferrocenophane, and the Cp rings have a dihedral angle of 11.6°. The structure of previuosly reported 2-benzylidene [3]ferrocenophane-1,3-dione exhibited a ~14° dihedral angle between Cp rings[31] while Hirao observed larger tilt angles around ~16° in the imide-bridged [3]ferrocenophane compounds.[30,32] The S-N bonds measure 1.6807(13) and 1.6854(12) Å and the S-N-S bond angle is 121.37(7)°. The remaining two angles about the nitrogen atom measure 118.43(10) and 118.74(10)°, and therefore the geometry about this atom is almost a perfect trigonal plane. We are continuing to develop this new “bioorganometallic” ferrecenophane as a reagent for the modification of amines via amide bond formation at the carboxylic acid functional group of the glycine.
Figure 2.

The molecular structure of 5 with 50% thermal ellipsoids. Hydrogen atoms have been omitted for clarity.
Conclusions
In summary, we have prepared three new ferrocene derivatives designed for conjugation with biological compounds. These complement the 1,1′-bis-(sulfonylchloride)ferrocene route to making bis(sulfonamide) derivatives and add to the toolbox of organometallic units that can be modified with compounds such as amino acids. Additionally, we observed that reaction of 1,1′-bis(sulfonylchloride)ferrocene and glycine methyl ester affords a new bioorganometallic ferrocenophane. We are continuing our investigations into methods for the covalent attachment of ferrocenes and other organometallic units onto molecules of biological interest.
Supplementary Material
Acknowledgments
The authors acknowledge the University of Akron and the College of the Holy Cross for support of this research. This work was also supported by grants from the National Institutes of Health (R15GM102805 and R15GM119030).
Footnotes
Supporting information for this article is given via a link at the end of the document. CCDC deposition numbers 1501463-1501466 contain the supplementary crystallographic data for this paper for compounds 2–5. This data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Supporting Information Summary
All experimental detail, spectroscopic and electrochemical data, and crystal data and refinement parameters of compounds 2–5 can be found in Supporting Information.
References
- 1.Mahmoud KA, Kraatz HB. Chem - A Eur J. 2007;13:5885–5895. doi: 10.1002/chem.200601878. [DOI] [PubMed] [Google Scholar]
- 2.Orlowski GA, Chowdhury S, Kraatz HB. Langmuir. 2007;23:12765–12770. doi: 10.1021/la701740q. [DOI] [PubMed] [Google Scholar]
- 3.Moriuchi T, Hirao T. Bioorganometallic Chem. Springer-Verlag; Berlin/Heidelberg: 2006. pp. 143–175. [Google Scholar]
- 4.Hillard E, Vessières A, Thouin L, Jaouen G, Amatore C. Angew Chemie Int Ed. 2006;45:285–290. doi: 10.1002/anie.200502925. [DOI] [PubMed] [Google Scholar]
- 5.Patra M, Gasser G, Wenzel M, Merz K, Bandow JE, Metzler-Nolte N. Organometallics. 2010;29:4312–4319. [Google Scholar]
- 6.Barišić L, Čakić M, Mahmoud KA, Liu Y, Kraatz HB, Pritzkow H, Kirin SI, Metzler-Nolte N, Rapić V. Chem - A Eur J. 2006;12:4965–4980. doi: 10.1002/chem.200600156. [DOI] [PubMed] [Google Scholar]
- 7.Chowdhury S, Schatte G, Kraatz HB. Angew Chemie Int Ed. 2008;47:7056–7059. doi: 10.1002/anie.200801460. [DOI] [PubMed] [Google Scholar]
- 8.Kirin SI, Wissenbach D, Metzler-Nolte N. New J Chem. 2005;29:1168–1173. [Google Scholar]
- 9.Metzler-Nolte N, van Staveran DR. Ferrocenes. John Wiley & Sons, Ltd; Chichester, UK: 2008. pp. 499–639. [Google Scholar]
- 10.Štěpnička Petr. Ferrocenes: Ligands, Materials and Biomolecules. John Wiley & Sons, Ltd; Chichester, UK: 2008. [Google Scholar]
- 11.Chanawanno K, Holstrom C, Crandall LA, Dodge H, Nemykin VN, Herrick RS, Ziegler CJ. Dalt Trans. 2016;45:14320–14326. doi: 10.1039/c6dt02669a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Knox GR, Pauson PL. J Chem Soc. 1958:692–696. [Google Scholar]
- 13.Poshkus aC, Herweh JE, Magnotta Fa. J Org Chem. 1963;28:2766–2769. [Google Scholar]
- 14.Grigoras C, Percec V. J Polym Sci Part A Polym Chem. 2005;43:319–330. [Google Scholar]
- 15.Lightfoot P, Tremayne M, Glidewell C, Harris KDM, Bruce PG. J Chem Soc Perkin Trans 2. 1993:1625–1630. [Google Scholar]
- 16.Arshad MN, Rahman MM, Asiri AM, Sobahi TR, Yu SH. RSC Adv. 2015;5:81275–81281. [Google Scholar]
- 17.Kinzhalov MA, Luzyanin KV, Boyarskiy VP, Haukka M, Kukushkin VY. Organometallics. 2013;32:5212–5223. [Google Scholar]
- 18.Han SY, Kim YA. Tetrahedron. 2004;60:2447–2467. [Google Scholar]
- 19.Corry AJ, Goel A, Kenny PTM. Inorganica Chim Acta. 2012;384:293–301. [Google Scholar]
- 20.Lamač M, Tauchman J, Dietrich S, Císařová I, Lang H, Štěpnička P. Appl Organomet Chem. 2010:326–331. [Google Scholar]
- 21.Tauchman J, Císařová I, Štěpnička P. Organometallics. 2009;28:3288–3302. [Google Scholar]
- 22.Mahmoud K, Long YT, Schatte G, Kraatz HB. Eur J Inorg Chem. 2005;2005:173–180. [Google Scholar]
- 23.Chahma M, Lee JS, Kraatz HB. J Organomet Chem. 2002;648:81–86. [Google Scholar]
- 24.Kraatz HB, Lusztyk J, Enright GD. Inorg Chem. 1997;36:2400–2405. doi: 10.1021/ic961454t. [DOI] [PubMed] [Google Scholar]
- 25.Palakurthy NB, Mandal B. Tetrahedron Lett. 2011;52:7132–7134. [Google Scholar]
- 26.Palakurthy NB, Dev D, Paikaray S, Chaudhury S, Mandal B. RSC Adv. 2014;4:7952–7958. [Google Scholar]
- 27.Musgrave RA, Russell AD, Manners I. Organometallics. 2013;32:5654–5667. [Google Scholar]
- 28.Osakada K, Sakano T, Horie M, Suzaki Y. Coord Chem Rev. 2006;250:1012–1022. [Google Scholar]
- 29.Heo RW, Lee TR. J Organomet Chem. 1999;578:31–42. [Google Scholar]
- 30.Moriuchi T, Hirao T, Ikeda I. Organometallics. 1995;14:3578–3580. [Google Scholar]
- 31.Gyepes E, Glowiak T, Toma S. J Organomet Chem. 1986;316:163–168. [Google Scholar]
- 32.Moriuchi T, Bandoh S, Miyaji Y, Hirao T. J Organomet Chem. 2000;599:135–142. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

